What is the recommended polyethylene glycol (PEG) disimpaction dose for a child with fecal impaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Polyethylene Glycol Disimpaction Dose in Pediatrics

For fecal disimpaction in children, administer PEG 3350 at 1.0 to 1.5 g/kg/day for 3 to 6 consecutive days, with the higher doses (1.0-1.5 g/kg/day) achieving significantly superior disimpaction rates (95%) compared to lower doses (55%). 1

Evidence-Based Dosing Protocol

Standard Disimpaction Regimen

  • Administer PEG 3350 at 1.5 g/kg/day for 4 consecutive days before any planned procedure, with a clear liquid diet on the fourth day 2, 3
  • For acute fecal impaction treatment, use 1.0 to 1.5 g/kg/day for 3 days minimum, as these doses achieve 95% disimpaction success versus only 55% with lower doses (0.25-0.5 g/kg/day) 1
  • Median time to complete disimpaction is 6 days (range 3-7 days) when using age-appropriate dosing: 4 sachets/day for ages 2-4 years, 6 sachets/day for ages 5-11 years 4

High-Dose Intensive Protocol (Severe Impaction)

  • For severe fecal impaction with palpable fecaloma, use 6-8 sachets (approximately 2-3 g/kg/day) on days 1-2, then reduce to 2-6 sachets on day 3, which produces median stool output of 2.2 liters over 7 days 5
  • Children begin defecating within 10-12 hours and reach maximum stool volume (approximately 1 liter/day) by day 2 6
  • This intensive regimen achieves 92% disimpaction success without requiring invasive interventions like enemas or hospitalization 4

Critical Safety Monitoring Requirements

Hydration Surveillance (Non-Negotiable)

  • Monitor clinical hydration status every 1-2 hours during preparation, specifically assessing capillary refill time, skin turgor, mucous membrane moisture, mental status, perfusion quality, and respiratory pattern 2, 3
  • Measure baseline body weight and monitor daily: 3-5% weight loss = mild dehydration, 6-9% = moderate dehydration, ≥10% = severe dehydration requiring immediate IV rehydration 2, 3
  • Track urine output, urine specific gravity, and ensure adequate oral fluid intake throughout the preparation period 3

Immediate IV Rehydration Triggers

  • Initiate isotonic IV fluids (lactated Ringer's or normal saline) immediately if any of the following occur: severe dehydration (≥10% fluid deficit) with shock or near-shock, altered mental status, inability to tolerate oral fluids, persistent vomiting, or serum sodium abnormalities 2, 3

Electrolyte Monitoring

  • Check serum electrolytes when clinical signs suggest abnormalities, particularly serum sodium (watch for <135 or >145 mmol/L), serum potassium (hypokalemia common with PEG), BUN, creatinine, and hematocrit 3

Comparative Efficacy and Safety

PEG vs. Enemas

  • PEG 1.5 g/kg/day for 6 days achieves 68% disimpaction success, comparable to enemas (80%, P=0.28), but causes more fecal incontinence and watery stools while avoiding the behavioral distress associated with enemas 7
  • Both treatments normalize colonic transit time equally (P=0.85), making them equivalent first-line options 7

PEG vs. Sodium Phosphate (Critical Safety Distinction)

  • PEG 3350 causes significantly fewer mucosal lesions (2.3%) compared to sodium phosphate (24.5%), making it the definitively safer choice 2, 8
  • Sodium phosphate preparations are absolutely contraindicated in children under 12 years due to risk of severe electrolyte disturbances, hyperphosphatemia, hypocalcemia, hypernatremia, and acute kidney injury 2, 8

Adverse Effects and Management

Expected Side Effects

  • Common adverse effects include nausea (5%), vomiting (5%), bloating (18%), cramping (5%), and diarrhea (13%), with bloating and diarrhea more prevalent at higher doses (1.0-1.5 g/kg/day) but not clinically prohibitive 1
  • No clinically significant electrolyte changes occur with PEG 3350 at disimpaction doses 1

Tolerance Optimization

  • To reduce nausea and vomiting, do not allow children to drink ad libitum from a cup or bottle; instead, use controlled administration with motivation techniques (e.g., making it a "race" to drink the laxatives) 6, 3

High-Risk Populations Requiring Dose Adjustment

  • Consider additional bowel purgatives or extended preparation time (beyond standard 3-4 days) in children with: prior inadequate bowel preparation, history of chronic constipation, prior colon resection, diabetes mellitus, spinal cord injury, or use of constipating medications (especially opioids) 2, 8, 3

Maintenance After Disimpaction

  • After successful disimpaction, reduce PEG 3350 to 1 sachet daily (approximately 0.4 g/kg/day) as maintenance therapy, titrating every 3 days based on stool frequency and consistency to achieve 1-2 soft stools per day 6, 9
  • PEG 3350 is significantly more effective than lactulose for preventing reimpaction (0% vs. 23% reimpaction rate, P=0.011) and maintains efficacy over 6 months without loss of effect 4, 9

Common Pitfalls to Avoid

  • Do not rely solely on sunken fontanelle or absence of tears to assess dehydration; these are less reliable than capillary refill, skin turgor, and perfusion 3
  • Do not ignore early signs of dehydration, as progression to severe dehydration constitutes a medical emergency 3
  • Do not use adjunctive agents (simethicone, prokinetics, spasmolytics, probiotics) routinely, as they are not recommended and provide no additional benefit 2, 8
  • Never use sodium phosphate preparations in children under 12 years, regardless of clinical scenario 2, 8

References

Guideline

Bowel Preparation in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Monitoring During Pediatric Bowel Preparation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Treatment of fecal impaction in children using combined polyethylene glycol and sodium picosulphate.

JGH open : an open access journal of gastroenterology and hepatology, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Polyethylene Glycol (PEG) 3350 Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.